FTC Set To Take Enforcement Action Against Drugmakers Over Orange Book Patent Listings

 
• By Brenda Sandburg
  
Orange Book
FTC targets improper patent listings in FDA's Orange Book • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Generics

More from Products